Home › Upcoming votes › Bio-Techne Corporation
This meeting took place on September 23, 2026. Bio-Techne Corporation reported the official results on Form 8-K, filed September 23, 2026 (read it on EDGAR); they are listed below. How funds voted appears on the company page after funds file Form N-PX, by August 31 after the proxy season ends on June 30.
Read the proxy statement on EDGARBio-Techne Corporation: past votes
Ballot read from the proxy statement and checked. As listed in Bio-Techne Corporation’s proxy statement, with the board’s recommendation on each item. The company has filed 2 sets of additional materials since; they can add to or change what is below, so check them before relying on it.
| # | Item | Proposed by | Board recommends | Last year (same kind of item) |
|---|---|---|---|---|
| 1 | MERGER AGREEMENT PROPOSAL | Board | For | — |
| 2 | NON-BINDING COMPENSATION ADVISORY PROPOSAL | Board | For | — |
| 3 | ADJOURNMENT PROPOSAL Adjournment |
Board | For | — |
From Bio-Techne Corporation’s Form 8-K, filed November 5, 2025, for the meeting held October 30, 2025 (read it on EDGAR). Support is the share of votes cast that were FOR: abstentions and broker non-votes are left out.
| Item | Support (of votes cast) | Reported outcome |
|---|---|---|
| 1. The shareholders voted to set the number of directors at nine | 99.7% | — |
| Elect Director: Robert V. Baumgartner | 95% | Elected |
| Elect Director: Julie L. Bushman | 97% | Elected |
| Elect Director: John L. Higgins | 96% | Elected |
| Elect Director: Kim Kelderman | 99.2% | Elected |
| Elect Director: Joseph D. Keegan | 97% | Elected |
| Elect Director: Alpna Seth | 96% | Elected |
| Elect Director: Rupert Vessey | 98% | Elected |
| Elect Director: Judith Klimovsky | 98% | Elected |
| Elect Director: Amy Herr | 99.0% | Elected |
| 3. A non-binding resolution approving the compensation of the Company's named executive officers, as described in the Proxy Statement | 72% | Approved |
| 4. The appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending June 30, 2026 | 98% | Approved |
The five managers that reported the most shares voted at Bio-Techne Corporation’s October 30, 2025 meeting, from their Form N-PX filings. This is how they voted then; it says nothing about how they will vote this time. Every manager’s vote.
| Item | Vanguard | BlackRock | T. Rowe Price | Invesco | ATLANTA CAPITAL MANAGEMENT CO L L C |
|---|---|---|---|---|---|
| 1. The shareholders voted to set the number of directors at nine | For | For | For | For | — |
| Elect Director: Robert V. Baumgartner | For | For | For | For | — |
| Elect Director: Julie L. Bushman | For | For | For | For | — |
| Elect Director: John L. Higgins | For | For | For | For | — |
| Elect Director: Kim Kelderman | For | For | For | For | — |
| Elect Director: Joseph D. Keegan | For | For | For | For | — |
| Elect Director: Alpna Seth | For | For | For | For | — |
| Elect Director: Rupert Vessey | For | For | For | For | — |
| Elect Director: Judith Klimovsky | For | For | For | For | — |
| Elect Director: Amy Herr | For | For | For | For | — |
| 3. A non-binding resolution approving the compensation of the Company's named executive officers, as described in the Pr | For | Mixed | Mixed | Against | For |
| 4. The appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending | For | For | For | For | — |
| Item | Support (of votes cast) | Reported outcome |
|---|---|---|
| Merger Agreement Proposal | 99.0% | — |
| Non-Binding Compensation Advisory Proposal: | 21% | — |
The meeting facts and ballot come from the SEC proxy filings listed above. Ballots are read from the proxy statement and checked against the filing’s own text; when that check does not pass, the page shows “see the proxy statement” instead of a ballot. Last year’s figures are the company’s official Form 8-K results and the managers’ Form N-PX reports. Nothing on this page predicts how any shareholder will vote, and it is not investment advice. How this works.